Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure
Benton R. Hunter, Lana Dbeibo, Christopher S. Weaver, Cole Beeler, Michele Saysana, Michelle K. Zimmerman, Lindsay Weaver
Abstract
Healthcare employees were tested for antibodies against severe acute respiratory coronavirus virus 2 (SARS-CoV-2). Among 734 employees, the prevalence of SARS-CoV-2 antibodies was 1.6%. Employees with heavy coronavirus disease 2019 (COVID-19) exposure had similar antibody prevalence as those with limited or no exposure. Guidelines for PPE use seem effective for preventing COVID-19 infection in healthcare workers.
Topics & Concepts
SeroprevalenceCoronavirusMedicineAntibodyVirologyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirusDiseaseHealth careImmunologySerologyInfectious disease (medical specialty)Internal medicineEconomic growthEconomicsSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesInfection Control and Ventilation